HCA
HCA Healthcare insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$434.92
+1.0% over 12 months
Share price and insider trades
HCA closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$31.1M
Insiders buying0
Insiders selling5
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.7×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 HCA Healthcare insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $31.1M. 0 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 57 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Feb 18SEC | Michael R McaleveyGeneral Counsel | Sell | 1,694 | $533.37 | $904K | -18.5% | — |
| Feb 12SEC | Jennifer BerresSvp & Chief Human Res. Officer | Sell | 4,010 | $526.16 | $2.1M | -17.3% | — |
| Feb 12SEC | Christopher F. WyattSvp & Controller | Sell | 4,000 | $505.00 | $2.0M | -13.9% | — |
| Feb 12SEC | Jennifer BerresSvp & Chief Human Res. Officer | Sell | 4,010 | $503.00 | $2.0M | -13.5% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 14,716 | $502.95 | $7.4M | -13.5% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 7,395 | $500.69 | $3.7M | -13.1% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 6,189 | $500.02 | $3.1M | -13.0% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 5,162 | $498.80 | $2.6M | -12.8% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 5,002 | $502.15 | $2.5M | -13.4% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 4,293 | $498.12 | $2.1M | -12.7% | — |
| Feb 5SEC | Michael S. CuffeEvp And Chief Clinical Officer | Sell | 1,500 | $498.09 | $747K | -12.7% | — |
| Feb 5SEC | Samuel N HazenCEO | Sell | 120 | $497.18 | $60K | -12.5% | — |
| Nov 5SEC | Michael R McaleveyGeneral Counsel | Sell | 3,892 | $473.79 | $1.8M | -8.2% | — |
Insiders at HCA Healthcare
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Samuel N HazenCEO | — | $21.5M | Feb 12, 2026 | — |
| Jennifer BerresSvp & Chief Human Res. Officer | — | $4.1M | Feb 12, 2026 | — |
| Michael R McaleveyGeneral Counsel | — | $2.7M | Aug 28, 2026 | — |
| Christopher F. WyattSvp & Controller | — | $2.0M | Feb 12, 2026 | — |
| Michael S. CuffeEvp And Chief Clinical Officer | — | $747K | Feb 12, 2026 | — |
| Mike A MarksCFO | — | — | May 11, 2026 | — |
| Thomas F Frist IIIDirector | — | — | Apr 30, 2026 | — |
| William R FristDirector | — | — | Apr 30, 2026 | — |
| John ChidseyDirector | — | — | Apr 30, 2026 | — |
| Nancy Ann DeparleDirector | — | — | Apr 30, 2026 | — |
| Hugh F JohnstonDirector | — | — | Apr 30, 2026 | — |
| Michael W MichelsonDirector | — | — | Apr 30, 2026 | — |
| Wayne Joseph RileyDirector | — | — | Apr 30, 2026 | — |
| Andrea B SmithDirector | — | — | Apr 30, 2026 | — |
| Jon M FosterCOO | — | — | Feb 12, 2026 | — |
| Erica RossittoSvp & Chief Nurse Executive | — | — | Feb 12, 2026 | — |
| Holding Frisco II10% Owner | — | — | Feb 10, 2026 | — |
| Holding Hercules II10% Owner | — | — | Feb 10, 2026 | — |
| Patricia F Elcan10% Owner | — | — | Feb 10, 2026 | — |
| Thomas F Frist Jr.10% Owner | — | — | Feb 10, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about HCA insiders
Are HCA Healthcare insiders buying HCA stock?
In the past 12 months, 0 insiders reported open-market purchases of HCA worth $0.
Are HCA Healthcare insiders selling HCA stock?
5 insiders reported sales worth $31.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.